transitioning from tirzepatide to semaglutide Transition: Clinical Dosing Guide – PlexusDx Switching GLP-1 Agonists for MAXIMUM

A comparative analysis found that non-diabetic patients with obesity on tirzepatide had a 64% lower risk of developing new-onset gastroparesis compared to those on semaglutide

In this part, lipid metabolites were sequentially analyzed in the livers of 70% mouse hepatectomy models at 0, 1, 3and 7 days after operation to find the changes of lipid metabolites in the process of liver regeneration

By upsetting iron homeostasis, heme-deficient proerythroblasts cause ferroptosis in hematopoietic stem and progenitor cells (HSPCs)

Comparison Table: Injectable Weight Loss Medications (for reference) Note: This table is for informational purposes only and should not be taken as medical advice

It is a retrospective case series, not a randomized controlled trial, for one

Data analysis is based on the Ct method with normalization of the raw data to housekeeping genes